Chapter 4 - Maya Takes the Chair
The emergency board meeting began at eight the next morning inside Vance Biomedical’s headquarters.
Maya entered through a private elevator accompanied by Agent Cole and two federal security officers.
The boardroom occupied the forty-seventh floor. Glass walls overlooked the Chicago River, and the long black table had been designed to intimidate investors, regulators, and employees.
For years, Maya had entered that room only during holiday parties.
David liked introducing her as his beautiful wife, never as the former forensic accountant who had once uncovered a thirty-million-dollar procurement scheme for the state.
That morning, every director stood when she arrived.
Some offered condolences.
Others avoided her eyes.
At the head of the table sat Richard Vance.
David’s father had returned from Singapore six hours earlier. At sixty-nine, Richard remained tall, silver-haired, and physically imposing. He wore a charcoal suit and the expression of a man accustomed to controlling every room he entered.
“Maya,” he said. “Sit beside me.”
She took the chair directly across from him.
“This meeting was called under my authority as temporary trustee of the Evelyn Vance Family Trust.”
Richard’s mouth tightened.
“That authority is being challenged.”
“Your attorneys may challenge it in court.”
“This company cannot survive a leadership war.”
“It may not survive what your son did.”
A few directors shifted uncomfortably.
Richard folded his hands.
“David has been arrested, not convicted.”
“The board does not need a criminal conviction to suspend an executive who exposed patients to contaminated medical products.”
“We don’t know that he did.”
Maya placed copies of the laboratory report in front of each director.
“We know Batch 47-C contained the bacterial strain found in my daughter’s blood.”
The room became silent.
Richard did not look at the report.
“This meeting should be postponed until independent experts review the results.”
“The FDA has already confirmed them.”
“You are grieving.”
“Yes.”
“You should not make irreversible decisions in this condition.”
Maya studied him.
“Was I grieving when your company transferred pediatric charity money to offshore accounts?”
Richard’s expression did not change, but two directors looked toward him.
Maya continued.
“Was I grieving when Nolan Price deleted safety warnings? Was I grieving when twelve million dollars disappeared into a shell company controlled by one of your former financial advisers?”
Richard leaned back.
“You have been speaking to federal investigators.”
“I have been giving them evidence.”
“That distinction may matter to you. It will not matter to shareholders.”
“It will matter to parents whose children received Batch 47-C.”
The board’s independent chair, Margaret Chen, cleared her throat.
“What action are you proposing?”
Maya opened a blue folder.
“First, permanent removal of David Vance as chief executive officer.”
Richard shook his head.
“You don’t have the votes.”
Maya looked at the corporate secretary.
“Please confirm the trust’s current voting rights.”
The secretary adjusted his glasses.
“Under the temporary succession provision, Mrs. Vance controls thirty-eight percent of voting shares.”
“And the directors supporting removal?”
Margaret raised her hand.
Five others followed.
Richard looked around the table.
“You are making a catastrophic mistake.”
“No,” Margaret said. “We made the mistake when we allowed your son to treat compliance as a public-relations inconvenience.”
The removal passed.
Maya did not feel satisfaction.
She thought of Lily’s science project sitting unfinished in storage.
“Second,” Maya continued, “I propose that Vance Biomedical voluntarily suspend distribution of all products manufactured at the Rockford facility until external testing is completed.”
“That will cost hundreds of millions,” Richard said.
“It may save lives.”
“You don’t know how business works.”
“I know exactly how fraud works.”
Richard’s gaze sharpened.
“Be careful, Maya.”
Agent Cole stepped closer to the table.
Richard glanced at him, then smiled faintly.
“Is that intimidation?”
“No,” Maya said. “That is protection.”
The suspension passed by a narrower margin.
“Third, I propose establishing an independent patient compensation fund using executive bonuses and restricted reserves.”
One director objected.
“You cannot seize earned compensation.”
“We can suspend distribution while the federal investigation determines whether the bonuses were obtained through fraudulent performance reports.”
Richard laughed coldly.
“You came prepared.”
“My daughter died while I was making emergency calls no one answered. I had time afterward.”
The compensation proposal passed.
Then Maya reached the final item.
“I nominate Dr. Elena Brooks as interim chief executive.”
The directors murmured.
Brooks was the company’s former head of clinical ethics. She had resigned two years earlier after repeated conflicts with David and Nolan.
Richard’s composure cracked.
“She is hostile to this company.”
“She was hostile to falsified data.”
“She will turn Vance Biomedical into a public confession.”
“Perhaps the public deserves one.”
A screen at the end of the boardroom illuminated.
Dr. Brooks appeared by video from Boston.
Her dark hair was streaked with gray, and her expression held none of the nervousness displayed by the directors.
“I will accept the position under three conditions,” she said. “Complete access to all records. Authority to remove any employee involved in data manipulation. And public disclosure of confirmed patient risks.”
Richard stood.
“This meeting is over.”
“No,” Maya said. “It is not.”
He looked at her across the table.
“You think controlling shares makes you powerful?”
“I think evidence makes me dangerous.”
Richard gathered his papers.
“You have no idea what you have stepped into.”
“My daughter stepped into your clinical program.”
“She was David’s daughter too.”
“Then perhaps you should ask why he placed the company’s valuation above her safety.”
Richard’s eyes became cold.
“You believe this begins and ends with David.”
Maya felt a shift in the room.
“What does that mean?”
Richard looked briefly toward Agent Cole.
Then he buttoned his jacket.
“It means grief has made you reckless.”
He left the boardroom.
The directors remained seated.
Maya watched the door close behind him.
Agent Cole leaned toward her.
“He knows where Nolan is.”
“I know.”
“He may also know more about the contamination than the current evidence shows.”
Maya looked at the empty chair Richard had occupied.
During her marriage, Richard had treated her with polished distance. He sent expensive birthday gifts, praised her parenting at formal dinners, and reminded David that public scandals damaged family value.
He had never once called Lily after she entered the hospital.
Not even after Maya’s messages reached his office.
Maya turned to the board.
“The vote on Dr. Brooks?”
One by one, the hands rose.
The nomination passed.
At 9:27 a.m., Maya became the most powerful shareholder inside Vance Biomedical.
At 9:31, the company issued its first public safety notice.
At 9:40, the stock price began collapsing.
At 9:52, Maya received a message from an unknown number.
You buried the wrong Vance.
She stared at the words.
A second message arrived.
David is weak. Richard is dangerous.
Then a photograph appeared.
It showed Maya leaving the cemetery after Lily’s funeral.
The image had been taken from behind a tree less than thirty feet from the grave.
Agent Cole took the phone from her.
“Do not respond.”
“Someone watched me bury her.”
“Yes.”
“Who?”
Cole enlarged the image.
In the reflection of a parked vehicle, a man’s face could be seen behind the camera.
Maya recognized him.
He was Samuel Keene, Vance Biomedical’s director of corporate security.
Richard’s most loyal employee.
Agent Cole immediately called his team.
But Samuel Keene had resigned that morning.
By the time agents reached his apartment, he was gone.
On his kitchen table, they found a one-way airline ticket to Toronto.
The flight had departed two hours earlier.
May you like
Beneath the ticket was a photograph of Lily.
A black line had been drawn through her face.
